National Academies Press: OpenBook
« Previous: Appendix A: Committee and Staff Biographies
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 203
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 204
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 205
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 206
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 207
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 208
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 209
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 210
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 211
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Page 212

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix B Committee Meeting Agendas Committee on Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response First Committee Meeting Agenda March 9, 2021 (7:00–10:00 a.m. EST) March 10, 2021 (7:00–9:00 a.m. EST) March 11, 2021 (7:00–9:00 a.m. EST) Meeting Objectives • Conduct committee and staff introductions and a bias/conflict of interest discussion • Orient the committee to the National Academies consensus study process • Hold an open session to hear from sponsoring agency (U.S. Department of Health and Human Services’ Office of Global Affairs) and the National Academy of Medicine’s International Committee on Advancing Pandemic and Seasonal Influenza Preparedness and Response, on their perspective of the Statement of Task and to hear from relevant stakeholders • Hold an open session to obtain background from speakers on the current global landscape for implementing and financing influenza vaccination and its barriers • Discuss the Statement of Task and devise a committee work plan • Identify information needs and future meeting topics 203

204 THE INFLUENZA IMPERATIVE Tuesday, March 9, 2021 OPEN SESSION 8:25 a.m. Welcome and Introductions Peter Sands, Committee Chair Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria 8:30 a.m. Speaker 1 and Discussion: The International Committee on Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response and Consensus Studies Prashant Yadav International Committee Cochair Senior Fellow Center for Global Development 8:40 a.m. Speaker 2 and Discussion: Sponsor Perspectives on the Charge to the Committee Larry Kerr Director, Pandemics and Emerging Threats Office of Global Affairs U.S. Department of Health and Human Services 9:10 a.m. Speaker 3 and Discussion: Envisioning Influenza at the World Health Organization: Global Frameworks and Partnerships for Influenza Vaccination Sylvie Briand Director, Global Infectious Hazard Preparedness World Health Organization 9:40 a.m. Adjourn Open Session Wednesday, March 10, 2021 OPEN SESSION 7:00 a.m. Welcome and Introductions Peter Sands, Committee Chair Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria

APPENDIX B 205 7:05 a.m. Speaker 1 and Discussion: Governance and Global Collaboration for Zoonotic Influenza and Vaccines Ian Brown Steering Committee Chairman OIE/FAO Network of Expertise on Animal Influenza (OFFLU) 7:30 a.m. Speaker 2 and Discussion: Contemporary Perspectives on Pathogen Sharing: The Pandemic Influenza Preparedness (PIP) Framework and the Nagoya Protocol Sangeeta Shashikant Legal Advisor Third World Network 8:00 a.m. Speaker 3 and Discussion: Global Partnerships for Influenza Vaccination Jeremy Farrar Director Wellcome Trust 8:30 a.m. Speaker 4 and Discussion: The Global Supply of Influenza Vaccines: Governance, Progress, and Areas for Growth Marie-Paule Kieny Director of Research Institut National de la Santé et la Recherche Médicale (INSERM) 8:55 a.m. Closing Remarks and Adjourn Day 2 Peter Sands, Committee Chair Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria

206 THE INFLUENZA IMPERATIVE Second Committee Meeting Agenda April 9, 2021 (8:00–11:00 a.m. EDT) April 16, 2021 (7:00–10:00 a.m. EDT) Friday, April 9, 2021 OPEN SESSION 8:55 a.m. Welcome and Introductions 9:00 a.m. Speaker 1 and Discussion: Update on Global Manufacturing Capacity and Access Barriers for Influenza Vaccines Thomas Cueni Chief Executive Officer, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) 9:35 a.m. Speaker 2 and Discussion: Potential Financing and Coordination Mechanisms for Pandemic Vaccination Nicole Lurie Strategic Advisor to the Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI) 10:10 a.m. Closing Remarks

APPENDIX B 207 Friday, April 16, 2021 OPEN SESSION 7:00 a.m. Welcome and Introductions 7:05 a.m. Speaker 1: Governance Structures and Barriers in the African Region for Influenza Vaccine Manufacturing Patrick Tippoo Executive Committee Vice President, Develop- ing Country Vaccine Manufacturing Network (DCVMN) Founding Member, African Vaccine Manufactur- ers Initiative (AVMI) Head of Science and Innovation, Biovac 7:35 a.m. Speaker 2: Current Challenges and Coordination Mechanisms in the MENA Region for Influenza Surveillance and Access Salah Al Awaidy Communicable Diseases Advisor, Ministry of Health, Oman 8:00 a.m. Speaker 3: The Developing Country Vaccine Manufacturers Network (DCVMN) and Current Challenges in Brazil for Influenza Vaccine Manufacturing Tiago Rocca Strategic Partnerships and Business Development Manager, Instituto Butantan Executive Committee Member, DCVMN 8:30 a.m. Closing Remarks

208 THE INFLUENZA IMPERATIVE Third Committee Meeting Agenda May 6, 2021 (8:00–10:00 a.m. EDT): Three simultaneous working group sessions May 7, 2021 (9:00–11:00 a.m. EDT): Three simultaneous working group sessions May 11, 2021 (1:00–1:45 p.m. EDT): Single working group session May 14, 2021 (8:00–11:00 a.m. EDT): Full committee session Meeting Objectives • Hold open sessions to obtain background from speakers on the current barriers for effective global health governance for pandemic influenza vac- cination, with a focus on pathogen sharing regulations, technology transfer partnerships, and global access and financing • Hold working group deliberations to form initial recommendations • Hold whole-committee meeting to discuss initial recommendations and next steps Thursday, May 6, 2021 OPEN SESSION 1: TECHNOLOGY AND MANUFACTURING WORKING GROUP 8:25 a.m. Welcome and Introductions Bruce Gellin Director, Global Immunization Sabin Vaccine Institute 8:30 a.m. Speaker 1: Public–Private Partnerships for Influenza Vaccine Development and Manufacturing and the Center for Infectious Disease Research and Policy’s (CIDRAP’s) Influenza Vaccine Research and Development Road Map Joseph Bresee Associate Director, Global Health Affairs, Influenza Division Director, Partnership for Influenza Vaccine Introduction U.S. Centers for Disease Control and Prevention Director, Global Funders Consortium for Universal Influenza Vaccine Development

APPENDIX B 209 8:55 a.m. Closing Remarks Friday, May 7, 2021 OPEN SESSION: PATHOGEN SHARING WORKING GROUP 9:30 a.m. Welcome and Introductions Alexandra Phelan Assistant Professor Center for Global Health Science and Security Georgetown University 9:35 a.m. Speaker 1: Speed and Equity for Pathogen and Vaccine Sharing at the World Health Organization Steven Solomon Principal Legal Officer, World Health Organization 10:00 a.m. Speaker 2: Environmental Health Law, the Nagoya Protocol, and Influenza Pathogen Sharing Jorge E. Viñuales Harold Samuel Chair of Law and Environmental Policy Founder and Former Director, Cambridge Centre for Environment, Energy and Natural Resource Government, Cambridge University 10:25 a.m. Closing Remarks Friday, May 7, 2021 OPEN SESSION 2: TECHNOLOGY AND MANUFACTURING WORKING GROUP 9:00 a.m. Welcome and Introductions Bruce Gellin Director, Global Immunization Sabin Vaccine Institute

210 THE INFLUENZA IMPERATIVE 9:05 a.m. Speaker 1: The Coalition for Epidemic Preparedness and Innovations’ (CEPI’s) Role as a Broker and Facilitator of Manufacturing Partnerships James Robinson CEPI Scientific Advisory Committee Vice Chair James Robinson Biologics Consulting 9:30 a.m. Closing Remarks Friday, May 7, 2021 OPEN SESSION: VACCINE ACCESS AND FINANCING WORKING GROUP 9:00 a.m. Opening Remarks Amanda Glassman Senior Fellow and Executive Vice President Center for Global Engagement 9:05 a.m. Speaker 1: Lessons from Economic Theory: Developing Quick Pandemic Vaccines and Distributing Them Equitably Gavin Yamey Associate Director for Policy and Professor of the Practice of Global Health and Public Policy Director, Center for Policy Impact in Global Health Duke Global Health Institute David McAdams Professor of Business Administration, Fuqua School of Business Professor of Economics, Economics Department Duke University Osondu Ogbuoji Assistant Research Professor Deputy Director, Center for Policy Impact in Global Health Duke Global Health Institute

APPENDIX B 211 S peaker 2: The World Bank’s Post-Pandemic 9:30 a.m. Emergency Financing Facility Agenda for Financing Pandemic Preparedness and Economic Theory for Incentivizing Vaccine Access Muhammad Ali Pate Global Director,  Health, Nutrition and Population (HNP) Global Practice World Bank 10:00 a.m. Speaker 3: Europe’s Experiences with Procuring COVID-19 Vaccines Andrzej Rys Director for Health Systems, Medical Products and Innovation Directorate-General for Health and Food Safety, European Commission 10:20 a.m. Closing Remarks Tuesday, May 11, 2021 OPEN SESSION 3: TECHNOLOGY AND MANUFACTURING WORKING GROUP 9:00 a.m. Welcome and Introductions Bruce Gellin Director, Global Immunization Sabin Vaccine Institute 1:00 p.m. Speaker 1: Lessons Learned from the Global Action Plan for Influenza Vaccines’ (GAP’s) Technology Transfer Partnerships and the Biomedical Advanced Research and Development Authority’s (BARDA’s) International Influenza Vaccine Technology Manufacturing Capacity Program Julie Schafer Chief Technology Officer Flu Lab Erin Sparrow Technical Officer World Health Organization 1:45 p.m. Closing Remarks

Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative Get This Book
×
Buy Paperback | $57.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The COVID-19 pandemic has laid bare the fragility of the global system of preparedness and response to pandemics and the fragmentation of our research and development ecosystem. The pandemic has provided a disruptive moment to advance new norms and frameworks for influenza. It also has demonstrated how innovative global public-private partnerships and coordination mechanisms can lead to rapid successes in viral vaccine research, manufacturing, and risk pooling.

Countering the Pandemic Threat Through Global Coordination on Vaccines identifies ways to strengthen pandemic and seasonal influenza global coordination, partnerships, and financing. This report presents seven overarching recommendations for how the urgent influenza threat should be conceptualized and prioritized within the global pandemic preparedness and response agenda in the future.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!